This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Institut Pasteur Korea, Korea Advanced Institute of Science and Technology. Active years: 2026.
Company Filing History:
1 out of 12 
1 out of 2,787 
Years Active: 2026
Title: Woo Dae Jang: Innovator in Pharmaceutical Composition for COVID-19
Introduction
Woo Dae Jang is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the context of combating coronavirus disease 2019 (COVID-19). His innovative approach utilizes drug repositioning technology to find new applications for existing medications.
Latest Patents
Woo Dae Jang holds 1 patent for a pharmaceutical composition aimed at preventing or treating COVID-19. This invention focuses on a composition derived from drug repositioning technology, which employs virtual screening methods to identify new uses for already established drugs. The advantage of this pharmaceutical composition lies in its reduced side effects compared to newly developed drugs, allowing for quicker implementation in clinical settings.
Career Highlights
Throughout his career, Woo Dae Jang has worked with prestigious institutions, including Institut Pasteur Korea and the Korea Advanced Institute of Science and Technology. His work has been pivotal in advancing the understanding and treatment of viral diseases, particularly in the context of the global pandemic.
Collaborations
Some of his notable coworkers include Sang Yup Lee and Seungtaek Kim. Their collaborative efforts have contributed to the success of his research and innovations in the pharmaceutical field.
Conclusion
Woo Dae Jang's contributions to the development of pharmaceutical compositions for COVID-19 highlight the importance of innovation in addressing global health challenges. His work exemplifies the potential of drug repositioning technology in creating effective treatments with fewer side effects.